Contrary to previous reports of STAT3 upregulation in breast cancer (11, 12), our integrated TCGA/GTEx analysis demonstrated higher constitutive expression in normal tissues, with survival analysis showing no significant prognostic impact of mRNA levels alone. The gene discussed is STAT3; the disease is breast carcinoma.